What is Aumolertinib used for?

Aumolertinib is used to treat various types of cancer, including non-small cell lung carcinoma and lung adenocarcinoma.

How does Aumolertinib work in the body?

It works as an epidermal growth factor receptor erbB1 inhibitor to target cancer cells.

Is Aumolertinib a small molecule drug?

Yes, Aumolertinib is classified as a small molecule.

What type of cancer can Aumolertinib treat?

It is studied for lung cancer, squamous cell carcinoma, and non-small cell lung carcinoma.

aumolertinib | CAS 1899921-05-1 | DOEOECWDNSEFDN

Loading compound...

Epidermal growth factor receptor (EGFR) inhibitor

Aumolertinib is a small molecule drug designed to treat certain types of cancer. It works by inhibiting the epidermal growth factor receptor erbB1 to help stop the growth of cancer cells.

How it worksAumolertinib works by blocking a specific protein called epidermal growth factor receptor erbB1, which helps prevent cancer cells from growing.

Used for

Non-small cell lung carcinomaLung adenocarcinomaLung cancerSquamous cell carcinoma

Conditions

Non-small cell lung carcinomaLung adenocarcinomaLung cancerSquamous cell carcinoma

Class

EGFR inhibitorSmall moleculeEpidermal growth factor receptor (EGFR) inhibitorRespiratory system

How to take

Information regarding specific administration instructions is not available in the provided data.

Talk to your doctor

Questions to ask

·Is Aumolertinib appropriate for my specific type of lung cancer?
·What are the expected benefits of Aumolertinib for my condition?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.

How to take

Talk to your doctor

Frequently asked questions (4)